Skylands Capital’s Idexx Laboratories IDXX Stock Holding History

Skylands Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,800	Closed	-$208K	–	207
2015 Q3	$208K	Hold	2,800	–	–	0.03%	189
2015 Q2	$180K	Hold	2,800	–	–	0.02%	211
2015 Q1	$216K	Sell	2,800 -200	-7%	-$15.6K	0.02%	200
2014 Q4	$222K	Sell	3,000 -42,000	-93%	-$2.95M	0.02%	198
2014 Q3	$2.65M	Buy	45,000 +35,000	+350%	+$2.21M	0.27%	84
2014 Q2	$668K	Sell	10,000 -8,000	-44%	-$509K	0.07%	183
2014 Q1	$1.09M	Sell	18,000 -2,000	-10%	-$119K	0.11%	139
2013 Q4	$1.06M	Sell	20,000 -24,350	-55%	-$1.28M	0.12%	142
2013 Q3	$2.21M	Buy	44,350 +10,150	+30%	+$488K	0.25%	91
2013 Q2	$1.53M	Buy	+34,200	New	+$1.49M	0.18%	108

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Skylands Capital's IDXX Position: Q4 2015 in Review

Skylands Capital sold out of Idexx Laboratories (IDXX) in Q4 2015, closing a stake of 2,800 shares — an estimated $208K sold.

Skylands Capital first reported a position in IDXX in Q2 2013 and held it in 10 quarters. The position peaked at $2.65M in Q3 2014. 351 funds tracked by Wall St. Rank hold IDXX as of Q4 2015.

Skylands Capital reported no remaining Idexx Laboratories position as of Q4 2015 after selling out during the quarter.
Skylands Capital sold 2,800 Idexx Laboratories shares in Q4 2015, an estimated $208K.
Skylands Capital first reported a position in Idexx Laboratories in Q2 2013 and held it in 10 quarters.
Skylands Capital's Idexx Laboratories position peaked at $2.65M in Q3 2014.
351 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2015.

Based on Skylands Capital's 13F filing for Q4 2015, filed 19 Jan 2016.